ZNI: (1R,5S,6r)-N-[(1P,7S,9S,13S,20M)-20-{5-(4-cyclopropylpiperazin-1-yl)-2-[(1S)-1-methoxyethyl]pyridin-3-yl}-21-ethyl-17,17-dimethyl-8,14-dioxo-15-oxa-4-thia-9,21,27,28-tetraazapentacyclo[17.5.2.1~2,5~.1~9,13~.0~22,26~]octacosa-1(24),2,5(28),19,22,25-hexaen-7-yl]-3-oxabicyclo[3.1.0]hexane-6-carboxamide
ZNI is a Ligand Of Interest in 9BHO designated by the Author
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with same target (top 5) |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 9BHO_ZNI_B_201 | 94% | 11% | 0.057 | 0.963 | 1.64 | 2.41 | 13 | 25 | 1 | 1 | 100% | 1 |
| 9BHO_ZNI_D_201 | 83% | 7% | 0.077 | 0.939 | 1.73 | 3.01 | 12 | 30 | 0 | 1 | 100% | 1 |
| 8TBN_ZNI_D_201 | 99% | 54% | 0.039 | 0.985 | 0.74 | 0.89 | 1 | - | 0 | 1 | 100% | 1 |
| 8TBK_ZNI_C_201 | 99% | 61% | 0.043 | 0.985 | 0.59 | 0.75 | 1 | - | 0 | 1 | 100% | 1 |
| 8TBF_ZNI_D_201 | 98% | 58% | 0.048 | 0.976 | 0.59 | 0.86 | - | 3 | 0 | 1 | 100% | 1 |
| 8TBL_ZNI_D_201 | 97% | 61% | 0.05 | 0.974 | 0.59 | 0.76 | 1 | 1 | 0 | 1 | 100% | 1 |
| 8TBI_ZNI_C_201 | 97% | 56% | 0.05 | 0.974 | 0.67 | 0.89 | 1 | 3 | 2 | 1 | 100% | 1 |
| 8TBM_ZNI_D_201 | 97% | 61% | 0.052 | 0.973 | 0.56 | 0.79 | 1 | - | 1 | 1 | 100% | 1 |
